QuiflaponAlternative Names: L 686708; MK 0591; MK 591
Latest Information Update: 18 Sep 1995
At a glance
- Originator Merck & Co
- Class Indoles; Quinolines
- Mechanism of Action 5-lipoxygenase activating protein inhibitors; Leukotriene inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma